118 related articles for article (PubMed ID: 34767964)
41. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2.
Zhou Y; Yang H; Xia W; Cui L; Xu R; Lu H; Xue D; Tian Z; Ding T; Cao Y; Shi Q; He X
J Biochem; 2020 Mar; 167(3):295-301. PubMed ID: 31790140
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
Liu DZ; Chang B; Li XD; Zhang QH; Zou YH
Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066
[TBL] [Abstract][Full Text] [Related]
43. LncRNA BDNF-AS suppresses colorectal cancer cell proliferation and migration by epigenetically repressing GSK-3β expression.
Zhi H; Lian J
Cell Biochem Funct; 2019 Jul; 37(5):340-347. PubMed ID: 31062382
[TBL] [Abstract][Full Text] [Related]
44. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
45. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.
Yin Y; Cai J; Meng F; Sui C; Jiang Y
Cancer Biol Ther; 2018 Apr; 19(4):306-315. PubMed ID: 29561704
[TBL] [Abstract][Full Text] [Related]
46. MiR-301b-3p Promotes the Occurrence and Development of Breast Cancer Cells via Targeting HOXA5.
Lu X; Duan J; Zhou R; Xu Y
Crit Rev Eukaryot Gene Expr; 2021; 31(3):35-44. PubMed ID: 34369713
[TBL] [Abstract][Full Text] [Related]
47. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
[TBL] [Abstract][Full Text] [Related]
48. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
[No Abstract] [Full Text] [Related]
49. E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells.
Rawat A; Gopisetty G; Thangarajan R
Cell Oncol (Dordr); 2014 Dec; 37(6):409-19. PubMed ID: 25338303
[TBL] [Abstract][Full Text] [Related]
50. RUNX3 inhibits the proliferation and metastasis of gastric cancer through regulating miR-182/HOXA9.
Yu J; Tian X; Chang J; Liu P; Zhang R
Biomed Pharmacother; 2017 Dec; 96():782-791. PubMed ID: 29054094
[TBL] [Abstract][Full Text] [Related]
51. Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion.
Grise F; Sena S; Bidaud-Meynard A; Baud J; Hiriart JB; Makki K; Dugot-Senant N; Staedel C; Bioulac-Sage P; Zucman-Rossi J; Rosenbaum J; Moreau V
Hepatology; 2012 Jun; 55(6):1766-75. PubMed ID: 22234932
[TBL] [Abstract][Full Text] [Related]
52. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
Borges S; Döppler H; Perez EA; Andorfer CA; Sun Z; Anastasiadis PZ; Thompson E; Geiger XJ; Storz P
Breast Cancer Res; 2013 Aug; 15(2):R66. PubMed ID: 23971832
[TBL] [Abstract][Full Text] [Related]
53. Discrete functional and mechanistic roles of chromodomain Y-like 2 (CDYL2) transcript variants in breast cancer growth and metastasis.
Yang LF; Yang F; Zhang FL; Xie YF; Hu ZX; Huang SL; Shao ZM; Li DQ
Theranostics; 2020; 10(12):5242-5258. PubMed ID: 32373210
[No Abstract] [Full Text] [Related]
54. Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line.
Buchegger K; Ili C; Riquelme I; Letelier P; Corvalán AH; Brebi P; Huang TH; Roa JC
Biol Res; 2016 Jan; 49():5. PubMed ID: 26796959
[TBL] [Abstract][Full Text] [Related]
55. HOXD9 promotes epithelial-mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma.
Lv X; Li L; Lv L; Qu X; Jin S; Li K; Deng X; Cheng L; He H; Dong L
J Exp Clin Cancer Res; 2015 Oct; 34():133. PubMed ID: 26514226
[TBL] [Abstract][Full Text] [Related]
56. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.
Wang J; Wang S; Zhou J; Qian Q
Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638
[TBL] [Abstract][Full Text] [Related]
57. A switch in RND3-RHOA signaling is critical for melanoma cell invasion following mutant-BRAF inhibition.
Klein RM; Higgins PJ
Mol Cancer; 2011 Sep; 10():114. PubMed ID: 21917148
[TBL] [Abstract][Full Text] [Related]
58. Long noncoding RNA NNT-AS1 functions as an oncogene in breast cancer via repressing ZFP36 expression.
Pan QH; Fan YH; Wang YZ; Li DM; Hu CE; Li RX
J Biol Regul Homeost Agents; 2020; 34(3):795-805. PubMed ID: 32691576
[TBL] [Abstract][Full Text] [Related]
59. Histone methyltransferase EZH2 in proliferation, invasion, and migration of fibroblast-like synoviocytes in rheumatoid arthritis.
Chang L; Zhou R
J Bone Miner Metab; 2022 Mar; 40(2):262-274. PubMed ID: 35083555
[TBL] [Abstract][Full Text] [Related]
60. UXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation.
McGilvray R; Walker M; Bartholomew C
FEBS J; 2007 Aug; 274(15):3960-71. PubMed ID: 17635584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
